BRAF and melanoma: Specifically, YAP confers resistance to BRAF inhibitors by inducing actin cytoskeleton remodeling in melanoma [48] and other tumors [49], and cytoskeletal tension itself has been shown to affect chemotherapeutic drug sensitivity of cancer cells [50].